![](https://www.microbiometimes.com/wp-content/uploads/2018/07/shutterstock_654407146-326x245.jpg)
4D announces publication of data showing potential of single bacterial strains from the human gut microbiota to serve as novel HDAC inhibitors
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announces the publication of data showing that specific single bacterial strains from the human gut microbiota have the potential to […]